Oscar Health, Inc. logo

Oscar Health, Inc. (OSCR)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
20. 50
-0.64
-3.03%
$
5.96B Market Cap
- P/E Ratio
- Div Yield
6,582,158 Volume
-0.16 Eps
$ 21.14
Previous Close
Add Transaction
Day Range
20.1 21.3
Year Range
10.69 25.58
Want to track OSCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oscar Health, Inc. (OSCR) Just Overtook the 20-Day Moving Average

Oscar Health, Inc. (OSCR) Just Overtook the 20-Day Moving Average

From a technical perspective, Oscar Health, Inc. (OSCR) is looking like an interesting pick, as it just reached a key level of support. OSCR recently overtook the 20-day moving average, and this suggests a short-term bullish trend.

Zacks | 1 day ago
After Golden Cross, Oscar Health, Inc. (OSCR)'s Technical Outlook is Bright

After Golden Cross, Oscar Health, Inc. (OSCR)'s Technical Outlook is Bright

Oscar Health, Inc. (OSCR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, OSCR's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

Zacks | 1 week ago
Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call Transcript

Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call Transcript

Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call Transcript

Seekingalpha | 4 weeks ago
Oscar Health Earnings Review: The Best Q1 Scenario We Could Hope For

Oscar Health Earnings Review: The Best Q1 Scenario We Could Hope For

Oscar Health (OSCR) delivered a standout Q1 2026, with $4.65B revenue, 52.7% YoY growth, and a 70.5% medical loss ratio. I reaffirm my Strong Buy rating and raise the 2026 price target to $30, citing robust execution and guidance reaffirmation. OSCR's SG&A leverage and technology platform drove operating efficiency, with Q1 Adjusted EBITDA at $727.1M and SG&A ratio likely below 15.8%.

Seekingalpha | 4 weeks ago
Oscar Health, Inc. (OSCR) Beats Q1 Earnings Estimates

Oscar Health, Inc. (OSCR) Beats Q1 Earnings Estimates

Oscar Health, Inc. (OSCR) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $1.21 per share. This compares to earnings of $0.92 per share a year ago.

Zacks | 4 weeks ago
Oscar Health Reports Record Profit As Obamacare Enrollment Jumps

Oscar Health Reports Record Profit As Obamacare Enrollment Jumps

Health insurer Oscar Health swung to a $679 million first quarter profit – the highest in company history – as its health plan membership jumped more than 50% and medical costs eased.

Forbes | 4 weeks ago
Why Oscar Health, Inc. (OSCR) Outpaced the Stock Market Today

Why Oscar Health, Inc. (OSCR) Outpaced the Stock Market Today

Oscar Health, Inc. (OSCR) closed the most recent trading day at $18.46, moving +2.96% from the previous trading session.

Zacks | 1 month ago
Investors Heavily Search Oscar Health, Inc. (OSCR): Here is What You Need to Know

Investors Heavily Search Oscar Health, Inc. (OSCR): Here is What You Need to Know

Oscar Health (OSCR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 1 month ago
Oscar Health, Inc. (OSCR) Surpasses Market Returns: Some Facts Worth Knowing

Oscar Health, Inc. (OSCR) Surpasses Market Returns: Some Facts Worth Knowing

In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $16.44, indicating a +1.67% shift from the previous trading day.

Zacks | 1 month ago
Oscar Health, Inc. (OSCR) Declines More Than Market: Some Information for Investors

Oscar Health, Inc. (OSCR) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $16.17, denoting a -1.64% move from the preceding trading day.

Zacks | 1 month ago
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note

Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note

In the closing of the recent trading day, Oscar Health, Inc. (OSCR) stood at $15.29, denoting a -1.23% move from the preceding trading day.

Zacks | 1 month ago
Oscar Health: A High-Growth Story With Significant Re-Rating Potential

Oscar Health: A High-Growth Story With Significant Re-Rating Potential

Oscar Health remains a "Buy" despite recent underperformance and a 7% stock drop since my last update. Management's 61% growth guidance sets high expectations; meeting it could drive positive price action and multiple expansion. Insider buying by the CEO boosts investor confidence in OSCR's outlook and execution.

Seekingalpha | 1 month ago
Loading...
Load More